Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Xu, Xiyan"" wg kryterium: Autor


Tytuł :
Update: Influenza Activity in the United States During the 2018-19 Season and Composition of the 2019-20 Influenza Vaccine.
Autorzy :
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Biggerstaff M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kondor R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Nyanseor S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Rolfes M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Stevens J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2019 Jun 21; Vol. 68 (24), pp. 544-551. Date of Electronic Publication: 2019 Jun 21.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Antiviral Agents/pharmacology ; Child ; Child Mortality ; Child, Preschool ; Cost of Illness ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/administration & dosage ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Seasons ; Severity of Illness Index ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.
Autorzy :
Gao J; Division of Viral Products, Center for Biologics Evaluation and Research, FDA, Silver Spring, Maryland, USA.
Couzens L; Division of Viral Products, Center for Biologics Evaluation and Research, FDA, Silver Spring, Maryland, USA.
Burke DF; Department of Zoology, University of Cambridge, Cambridge, United Kingdom.
Wan H; Division of Viral Products, Center for Biologics Evaluation and Research, FDA, Silver Spring, Maryland, USA.
Wilson P; Department of Medicine, University of Chicago, Chicago, Illinois, USA.
Memoli MJ; Laboratory of Infectious Diseases, NIAID, National Institutes of Health, Bethesda, Maryland, USA.
Xu X; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Harvey R; National Institute of Biological Standards and Control, MHRA, South Mimms, United Kingdom.
Wrammert J; Emory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
Ahmed R; Emory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
Taubenberger JK; Laboratory of Infectious Diseases, NIAID, National Institutes of Health, Bethesda, Maryland, USA.
Smith DJ; Department of Zoology, University of Cambridge, Cambridge, United Kingdom.
Fouchier RAM; Department of Virology, Erasmus Medical Center, Rotterdam, Netherlands.
Eichelberger MC; Division of Viral Products, Center for Biologics Evaluation and Research, FDA, Silver Spring, Maryland, USA .
Pokaż więcej
Źródło :
MBio [mBio] 2019 Apr 09; Vol. 10 (2). Date of Electronic Publication: 2019 Apr 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Genetic Drift*
Antibodies, Viral/*immunology
Antigens, Viral/*immunology
Influenza A Virus, H1N1 Subtype/*immunology
Neuraminidase/*immunology
Viral Proteins/*immunology
Animals ; Antibodies, Monoclonal/immunology ; Disease Models, Animal ; Ferrets ; Immune Evasion ; Immunization, Passive ; Influenza A Virus, H1N1 Subtype/genetics ; Mice ; Neuraminidase/genetics ; Orthomyxoviridae Infections/prevention & control ; Survival Analysis ; Treatment Outcome ; Viral Proteins/genetics
Czasopismo naukowe
Tytuł :
Update: Influenza Activity - United States, September 30, 2018-February 2, 2019.
Autorzy :
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Abd Elal AI; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Reed C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Rolfes M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2019 Feb 15; Vol. 68 (6), pp. 125-134. Date of Electronic Publication: 2019 Feb 15.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Prevalence ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Influence of Immune Priming and Egg Adaptation in the Vaccine on Antibody Responses to Circulating A(H1N1)pdm09 Viruses After Influenza Vaccination in Adults.
Autorzy :
Liu F; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Tzeng WP; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Horner L; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.; Battelle Memorial Institute, Atlanta, Georgia.
Kamal RP; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.; Battelle Memorial Institute, Atlanta, Georgia.
Tatum HR; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.; Battelle Memorial Institute, Atlanta, Georgia.
Blanchard EG; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Xu X; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
York I; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Tumpey TM; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Katz JM; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Lu X; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Levine MZ; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2018 Oct 05; Vol. 218 (10), pp. 1571-1581.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Influenza A Virus, H1N1 Subtype/*immunology
Influenza Vaccines/*immunology
Influenza, Human/*immunology
Influenza, Human/*virology
Adolescent ; Adult ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Humans ; Influenza, Human/blood ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity in the United States During the 2017-18 Season and Composition of the 2018-19 Influenza Vaccine.
Autorzy :
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Biggerstaff M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Davis T; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jang Y; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lindstrom S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2018 Jun 08; Vol. 67 (22), pp. 634-642. Date of Electronic Publication: 2018 Jun 08.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Seasons ; Severity of Illness Index ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity - United States, October 1, 2017-February 3, 2018.
Autorzy :
Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Davis T; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Flannery B; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jang Y; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lindstrom S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Olsen SJ; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2018 Feb 16; Vol. 67 (6), pp. 169-179. Date of Electronic Publication: 2018 Feb 16.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Ambulatory Care/statistics & numerical data ; Antiviral Agents/pharmacology ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Female ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza, Human/mortality ; Influenza, Human/virology ; Male ; Middle Aged ; Pneumonia/mortality ; Pregnancy ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity - United States, October 1-November 25, 2017.
Autorzy :
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Davis T; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Flannery B; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jang Y; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lindstrom S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Olsen SJ; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Trock S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2017 Dec 08; Vol. 66 (48), pp. 1318-1326. Date of Electronic Publication: 2017 Dec 08.
Typ publikacji :
Journal Article
MeSH Terms :
Disease Outbreaks*
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H1N2 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N2 Subtype/drug effects ; Influenza A Virus, H1N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza, Human/mortality ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/epidemiology ; Pneumonia/mortality ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity - United States and Worldwide, May 21-September 23, 2017.
Autorzy :
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Azziz-Baumgartner E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Davis CT; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Grohskopf LA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lindstrom S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Olsen SJ; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Roguski K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Trock S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2017 Oct 06; Vol. 66 (39), pp. 1043-1051. Date of Electronic Publication: 2017 Oct 06.
Typ publikacji :
Journal Article
MeSH Terms :
Disease Outbreaks*
Population Surveillance*
Global Health/*statistics & numerical data
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Centers for Disease Control and Prevention, U.S. ; Humans ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/genetics ; Seasons ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Update: Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine.
Autorzy :
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Chung J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Flannery B; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan V; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2017 Jun 30; Vol. 66 (25), pp. 668-676. Date of Electronic Publication: 2017 Jun 30.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H1N2 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza A Virus, H7N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Coinfection ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N2 Subtype/drug effects ; Influenza A Virus, H1N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza A Virus, H7N2 Subtype/drug effects ; Influenza A Virus, H7N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity - United States, October 2, 2016-February 4, 2017.
Autorzy :
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Bresee J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AI; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2017 Feb 17; Vol. 66 (6), pp. 159-166. Date of Electronic Publication: 2017 Feb 17.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H1N2 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza A Virus, H7N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Antiviral Agents/pharmacology ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Female ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza, Human/mortality ; Influenza, Human/virology ; Male ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Pregnancy ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Update: Influenza Activity - United States, October 2-December 17, 2016.
Autorzy :
Shang M
Blanton L
Kniss K
Mustaquim D
Alabi N
Barnes S
Budd A
Davlin SL
Kramer N
Garg S
Cummings CN
Flannery B
Fry AM
Grohskopf LA
Olsen SJ
Bresee J
Sessions W
Garten R
Xu X
Elal AI
Gubareva L
Barnes J
Wentworth DE
Burns E
Katz J
Jernigan D
Brammer L
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2016 Dec 30; Vol. 65 (50-51), pp. 1439-1444. Date of Electronic Publication: 2016 Dec 30.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Ambulatory Care/statistics & numerical data ; Antiviral Agents/pharmacology ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N2 Subtype/isolation & purification ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza, Human/mortality ; Influenza, Human/virology ; Middle Aged ; Pneumonia/mortality ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine.
Autorzy :
Davlin SL
Blanton L
Kniss K
Mustaquim D
Smith S
Kramer N
Cohen J
Cummings CN
Garg S
Flannery B
Fry AM
Grohskopf LA
Bresee J
Wallis T
Sessions W
Garten R
Xu X
Elal AI
Gubareva L
Barnes J
Wentworth DE
Burns E
Katz J
Jernigan D
Brammer L
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2016 Jun 10; Vol. 65 (22), pp. 567-75. Date of Electronic Publication: 2016 Jun 10.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Selection of antigenically advanced variants of seasonal influenza viruses.
Autorzy :
Li C; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Hatta M; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Burke DF; Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.; World Health Organization Collaborating Centre for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK.
Ping J; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Zhang Y; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Ozawa M; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.; Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
Taft AS; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Das SC; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Hanson AP; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Song J; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Imai M; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.; Department of Veterinary Medicine, Faculty of Agriculture, Iwate University, Iwate 020-8550, Japan.
Wilker PR; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Watanabe T; ERATO Infection-Induced Host Responses Project, Saitama 332-0012, Japan.
Watanabe S; ERATO Infection-Induced Host Responses Project, Saitama 332-0012, Japan.
Ito M; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
Iwatsuki-Horimoto K; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
Russell CA; World Health Organization Collaborating Centre for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK.; Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA.; Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK.
James SL; Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.; World Health Organization Collaborating Centre for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK.
Skepner E; Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.; World Health Organization Collaborating Centre for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK.
Maher EA; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Neumann G; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.
Klimov AI; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA.
Kelso A; WHO Collaborating Centre for Reference and Research on Influenza (VIDRL) at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia.
McCauley J; Division of Virology, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom.
Wang D; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Shu Y; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Odagiri T; Influenza Virus Research Center, National Institute of Infectious Diseases, Musashi-Murayama, Tokyo 208-0011, Japan.
Tashiro M; Influenza Virus Research Center, National Institute of Infectious Diseases, Musashi-Murayama, Tokyo 208-0011, Japan.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA.
Katz JM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA.
Cox NJ; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA.
Smith DJ; Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.; World Health Organization Collaborating Centre for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK.; Department of Virology, Erasmus Medical Center, 3000 CA Rotterdam, Netherlands.
Kawaoka Y; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA.; Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.; ERATO Infection-Induced Host Responses Project, Saitama 332-0012, Japan.; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
Pokaż więcej
Źródło :
Nature microbiology [Nat Microbiol] 2016 May 23; Vol. 1 (6), pp. 16058. Date of Electronic Publication: 2016 May 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigenic Variation*
Antigens, Viral/*genetics
Influenza A Virus, H1N1 Subtype/*genetics
Influenza A Virus, H1N1 Subtype/*immunology
Influenza A Virus, H3N2 Subtype/*genetics
Influenza A Virus, H3N2 Subtype/*immunology
Influenza, Human/*prevention & control
Amino Acid Substitution ; Animals ; Antigens, Viral/immunology ; Evolution, Molecular ; Ferrets/immunology ; Hemagglutinin Glycoproteins, Influenza Virus/chemistry ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Hemagglutinin Glycoproteins, Influenza Virus/immunology ; Humans ; Immune Evasion ; Influenza Vaccines/genetics ; Influenza Vaccines/immunology ; Influenza, Human/epidemiology ; Mice ; Orthomyxoviridae Infections/prevention & control ; Seasons
Czasopismo naukowe
Tytuł :
Update: Influenza Activity--United States and Worldwide, May 24-September 5, 2015.
Autorzy :
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K
Smith S
Mustaquim D
Steffens C
Flannery B
Fry AM
Bresee J
Wallis T
Garten R
Xu X
Elal AI
Gubareva L
Wentworth DE
Burns E
Katz J
Jernigan D
Brammer L
Pokaż więcej
Źródło :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2015 Sep 18; Vol. 64 (36), pp. 1011-6. Date of Electronic Publication: 2015 Sep 18.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Global Health/*statistics & numerical data
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Humans ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/genetics ; Seasons ; United States/epidemiology
Czasopismo naukowe
Tytuł :
WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.
Autorzy :
Barr IG; WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory (VIDRL), Melbourne, Australia. Electronic address: .
Russell C; University of Cambridge, UK.
Besselaar TG; WHO Global Influenza Programme (GIP), Geneva, Switzerland.
Cox NJ; WHO Collaborating Centre for Surveillance, Epidemiology and Control of Influenza, Centers for Disease Control and Prevention, Atlanta, USA.
Daniels RS; WHO Collaborating Centre for Reference and Research on Influenza, Medical Research Council - National Institute for Medical Research (NIMR), London, UK.
Donis R; WHO Collaborating Centre for Surveillance, Epidemiology and Control of Influenza, Centers for Disease Control and Prevention, Atlanta, USA.
Engelhardt OG; National Institute for Biological Standards and Control (NIBSC), Health Protection Agency (HPA), Potters Bar, UK.
Grohmann G; Therapeutic Goods Administration (TGA), Canberra, Australia.
Itamura S; WHO Collaborating Centre for Reference and Research on Influenza, National Institute of Infectious Diseases (NIID), Tokyo, Japan.
Kelso A; WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory (VIDRL), Melbourne, Australia.
McCauley J; WHO Collaborating Centre for Reference and Research on Influenza, Medical Research Council - National Institute for Medical Research (NIMR), London, UK.
Odagiri T; WHO Collaborating Centre for Reference and Research on Influenza, National Institute of Infectious Diseases (NIID), Tokyo, Japan.
Schultz-Cherry S; St Jude Children's Research Hospital, Memphis, USA.
Shu Y; WHO Collaborating Center for Reference and Research on Influenza, Chinese National Influenza Center (CNIC), Beijing, PR China.
Smith D; Centre for Pathogen Evolution and WHOCC for Modelling Evolution and Control of Emerging Infectious Diseases, University of Cambridge, UK and Fogarty International Centre, National Institutes of Health (NIH), USA.
Tashiro M; WHO Collaborating Centre for Reference and Research on Influenza, National Institute of Infectious Diseases (NIID), Tokyo, Japan.
Wang D; WHO Collaborating Center for Reference and Research on Influenza, Chinese National Influenza Center (CNIC), Beijing, PR China.
Webby R; St Jude Children's Research Hospital, Memphis, USA.
Xu X; WHO Collaborating Centre for Surveillance, Epidemiology and Control of Influenza, Centers for Disease Control and Prevention, Atlanta, USA.
Ye Z; Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Bethesda, MD, USA.
Zhang W; WHO Global Influenza Programme (GIP), Geneva, Switzerland.
Pokaż więcej
Corporate Authors :
Writing Committee of the World Health Organization Consultation on Northern Hemisphere Influenza Vaccine Composition for 2013–2014
Źródło :
Vaccine [Vaccine] 2014 Aug 20; Vol. 32 (37), pp. 4713-25. Date of Electronic Publication: 2014 Feb 28.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A Virus, H1N1 Subtype*/genetics
Influenza A Virus, H1N1 Subtype*/immunology
Influenza A Virus, H3N2 Subtype*/genetics
Influenza A Virus, H3N2 Subtype*/immunology
Influenza B virus*/genetics
Influenza B virus*/immunology
Influenza Vaccines/*therapeutic use
Influenza, Human/*epidemiology
Humans ; Influenza, Human/prevention & control ; World Health Organization
Czasopismo naukowe
Tytuł :
Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.
Autorzy :
Lu X; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Liu F; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Zeng H; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Sheu T; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Achenbach JE; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Veguilla V; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Gubareva LV; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Garten R; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Smith C; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Yang H; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Stevens J; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Xu X; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Katz JM; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Tumpey TM; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. Electronic address: .
Pokaż więcej
Źródło :
Virology [Virology] 2014 Apr; Vol. 454-455, pp. 169-75. Date of Electronic Publication: 2014 Mar 05.
Typ publikacji :
Journal Article
MeSH Terms :
Cross Protection*
Cross Reactions*
Antigens, Viral/*immunology
Influenza A Virus, H1N1 Subtype/*immunology
Influenza A Virus, H5N1 Subtype/*immunology
Neuraminidase/*immunology
Viral Proteins/*immunology
Animals ; Antigens, Viral/genetics ; Disease Models, Animal ; Enzyme-Linked Immunosorbent Assay ; Female ; Immunization, Passive ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H5N1 Subtype/genetics ; Mice ; Mice, Inbred BALB C ; Neuraminidase/genetics ; Neutralization Tests ; Orthomyxoviridae Infections/prevention & control ; Rabbits ; Viral Plaque Assay ; Viral Proteins/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies